Equities Analysts Offer Predictions for Maximus Q3 Earnings

Maximus, Inc. (NYSE:MMS - Free Report) - Analysts at Zacks Research reduced their Q3 2025 earnings per share estimates for Maximus in a report released on Thursday, May 29th. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings of $1.42 per share for the quarter, down from their prior estimate of $1.50. The consensus estimate for Maximus' current full-year earnings is $6.15 per share. Zacks Research also issued estimates for Maximus' Q4 2025 earnings at $1.48 EPS, FY2025 earnings at $6.52 EPS, Q1 2026 earnings at $1.46 EPS, Q2 2026 earnings at $1.39 EPS, Q4 2026 earnings at $1.56 EPS, FY2026 earnings at $5.98 EPS, Q1 2027 earnings at $1.00 EPS and FY2027 earnings at $5.28 EPS.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The company's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.57 EPS.

Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Maximus Trading Down 1.1%

NYSE:MMS traded down $0.82 on Monday, hitting $70.12. The stock had a trading volume of 470,343 shares, compared to its average volume of 564,674. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock has a market cap of $3.95 billion, a price-to-earnings ratio of 15.08 and a beta of 0.61. The company has a fifty day moving average price of $70.19 and a two-hundred day moving average price of $71.38. Maximus has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.71%. The ex-dividend date was Thursday, May 15th. Maximus's dividend payout ratio (DPR) is presently 23.86%.

Insider Activity

In other news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director now directly owns 14,205 shares in the company, valued at $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Hedge Funds Weigh In On Maximus

Hedge funds and other institutional investors have recently bought and sold shares of the company. V Square Quantitative Management LLC lifted its position in shares of Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares in the last quarter. LRI Investments LLC increased its stake in Maximus by 11.9% during the 1st quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock worth $125,000 after buying an additional 195 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock worth $2,351,000 after buying an additional 221 shares during the period. Vestcor Inc lifted its holdings in Maximus by 2.3% during the 1st quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after buying an additional 223 shares in the last quarter. Finally, Hillsdale Investment Management Inc. lifted its holdings in Maximus by 0.4% during the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock worth $3,912,000 after buying an additional 230 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.